Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$7,303.02
% of Total Estimate Gain
19.21%

Disciplined U.S. Value Equity Portfolio's United Therapeutics Corp Holding Summary

As of 2025-04-30, Disciplined U.S. Value Equity Portfolio held - shares of United Therapeutics Corp(UTHR), totaling N/A. This investment constitutes 0% of their stock portfolio, and Disciplined U.S. Value Equity Portfolio now holds 0% of the outstanding United Therapeutics Corp(UTHR) stock.

The initial trade took place in 2023Q3. And since then Disciplined U.S. Value Equity Portfolio has made 3 purchases of UTHR, at an average price of $250.07, for a total of 152.00 shares. In addition, there have been 2 sales at an average price of $298.12 for 152.00 shares. Based on historical transaction data and UTHR's current price of $289.58, Disciplined U.S. Value Equity Portfolio's estimated gain on his UTHR holdings is $7,303.02, reflecting a 19.21% gain to date.

Disciplined U.S. Value Equity Portfolio UTHR ($289.58) Holding Chart

Disciplined U.S. Value Equity Portfolio UTHR ($289.58) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1